STOCK TITAN

If You Invested in POMDOCTOR LTD (POM)

Healthcare · Pharmaceutical Retailers · NASDAQ
Looking for the current price? See the POM quote & overview
$1,000 invested 1 Year Ago
$9
-99.1% total -99.7% CAGR
Bought on Oct 8, 2025 at $72.54
$1,000 invested 5 Years Ago
$0
-100.0% total -86.2% CAGR
Bought on Jul 29, 2021 at $13500.00

What $1,000 or $10,000 in POM Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jul 30, 2015
$1,000 $9 -99% $0 -100% $0 -100% $0 -100%
$10,000 $94 -99% $1 -100% $1 -100% $2 -100%

Based on real historical closing prices, dividend- and split-adjusted, through 2026-07-28. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for POM

$1,000 Investment Over Time

POM vs S&P 500

Year-by-Year Returns

POM annual performance
Year Start Price End Price Annual Return Cumulative
2015 $4481.61 $4615.38 +3.0% +3.0%
2016 $4615.38 $5418.06 +17.4% +20.9%
2017 $5672.24 $10668.90 +88.1% +138.1%
2018 $10702.30 $6739.13 -37.0% +50.4%
2019 $7565.22 $5217.39 -31.0% +16.4%
2020 $5130.43 $12800.00 +149.5% +185.6%
2021 $13650.00 $14650.00 +7.3% +226.9%
2022 $14650.00 $14500.00 -1.0% +223.5%
2025 $72.54 $5.31 -92.7% -99.9%
2026 $5.87 $0.6802 -88.4% -100.0%

About POMDOCTOR LTD

Healthcare · NASDAQ

POMDOCTOR LIMITED (NASDAQ: POM) is described as an online medical services platform for chronic diseases in China. According to company disclosures, Pomdoctor focuses on chronic disease management and pharmaceutical services, using a one-stop platform model that connects patients with doctors and pharmaceutical products.

The company states that its operations primarily include two segments: Internet hospital and pharmaceutical supply chain. Through these segments, Pomdoctor connects users, pharmacies, suppliers, medical professionals, and other healthcare participants. Its model is intended to enhance the efficiency and transparency of the healthcare value chain in China by bringing together medical consultation and access to pharmaceutical products on a single platform.

Pomdoctor notes that its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. Over time, this has evolved into an Internet hospital business and a pharmaceutical supply chain business that together form its one-stop medical services platform. The company has indicated that the majority of its revenue is derived from its pharmaceutical supply chain segment.

Based on information cited from Frost & Sullivan in company materials, Pomdoctor reports that it ranked sixth in China’s Internet hospital market by number of contracted doctors in 2022. The company describes itself as a leading online medical services platform for chronic diseases in China, reflecting this position in the contracted-doctor segment of the Internet hospital market.

Pomdoctor’s Internet hospital operations include online medical services for chronic diseases and online pharmacy sales conducted through its Internet hospital platform. The company has reported strengthening cooperation with pharmaceutical manufacturers to sell their products through this platform, which has contributed to growth in its online pharmacy sales and net revenues from the Internet hospital segment.

The pharmaceutical supply chain segment, as described by Pomdoctor, involves supplying pharmacy products and working with pharmacy wholesale customers. The company has disclosed that changes in the gross profit margin of this segment can be influenced by the characteristics of newly acquired pharmacy wholesale customers compared with existing customers.

Pomdoctor’s business is closely tied to China’s evolving healthcare landscape. The company has highlighted efforts to expand market coverage and penetration while promoting its Internet hospital services and online sales. It has also discussed measures such as offering higher service fees to partner doctors and enhancing collaboration with pharmaceutical manufacturers as part of its approach to growing its chronic disease-focused online medical services platform.

In its own description of its mission and vision, Pomdoctor states that its mission is to provide effective prevention and treatment solutions to alleviate patients’ suffering from illnesses, and its vision is to become what it calls the most trustworthy medical and healthcare services platform. These stated goals align with its focus on chronic disease management and the integration of medical consultation and pharmaceutical services.

POMDOCTOR LIMITED’s American Depositary Shares trade on the Nasdaq Global Market under the ticker symbol POM. The company has disclosed that its ADSs began trading on the Nasdaq Global Market under this symbol following the pricing and closing of its initial public offering.

Market Cap
$0.0B
Current Price
$0.6802
EPS
$-3.14
Revenue
$0.1B
Net Margin
-32.7%
View full POM overview

Frequently Asked Questions

POMDOCTOR LTD investment returns

How much would $1,000 invested in POMDOCTOR LTD be worth today?

If you invested $1,000 in POMDOCTOR LTD (POM) 10 years ago on 2016-07-29, your investment would be worth $0 as of 2026-07-28, representing a -100.0% total return, growing at a compounded rate of -59.8% per year (CAGR).

Has POMDOCTOR LTD outperformed the S&P 500?

Over the past 10 years, POM returned -100.0% compared to +291.3% for the S&P 500, underperforming the benchmark by 391.3 percentage points.

What is POMDOCTOR LTD's average annual return?

The compound annual growth rate (CAGR) of POM over the past 10 years is -59.8%, growing at a compounded rate each year. Individual years vary significantly — POM's best recent year was 2020 (+149.5%) and worst was 2025 (-92.7%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.